Medicare Enrolled

Dr. Husna Siddiqui, MD

Rheumatology · Elgin, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1550 N RANDALL RD, Elgin, IL 60123
8153989491
In practice since 2016 (10 years)
NPI: 1396108825 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Siddiqui from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Siddiqui? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Siddiqui

Dr. Husna Siddiqui is a rheumatology specialist in Elgin, IL, with 10 years of NPI registration. Based on federal Medicare data, Dr. Siddiqui performed 38,074 Medicare services across 991 unique beneficiaries.

Between the years covered by Open Payments, Dr. Siddiqui received a total of $3,817 from 17 pharmaceutical and/or device companies across 166 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Siddiqui is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice ▲ Top 21% volume in IL $3,817 industry payments

Medicare Practice Summary

Medicare Utilization ↗
38,074
Medicare services
Top 21% in IL for rheumatology
991
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,807 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tocilizumab injection (Actemra) 24,080 $5 $25
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
6,050 $10 $73
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
3,650 $34 $173
Denosumab injection (Prolia/Xgeva) 1,680 $19 $91
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
1,140 $26 $258
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
311 $97 $318
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
180 $65 $215
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
135 $12 $74
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
105 $120 $490
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
93 $105 $595
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
92 $1 $21
X-ray of hand, minimum of 3 views
An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints.
76 $56 $234
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
73 $53 $293
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
70 $4 $23
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
66 $1 $7
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
64 $12 $62
X-ray of hand, 2 views
An X-ray imaging test of the hand using two different angles to visualize the bones and joints.
41 $40 $191
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
40 $142 $430
Knee X-ray, 3 views
An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures.
30 $56 $252
New patient office visit, complex (60-74 min) 26 $180 $958
Bone density scan (DEXA) of hip, pelvis, and spine
This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures.
23 $54 $220
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
17 $57 $339
Shoulder X-ray, 2+ views
An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures.
16 $38 $190
Foot X-ray, 3+ views
An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints.
16 $54 $226
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
28.9% high complexity
68.8% medium
2.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,817
Total received (2019-2024)
Avg $763/year across 5 years
Top 35% in IL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
17
Companies
166
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,817 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,689
2023
$856
2022
$207
2021
$52
2019
$12

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$856
Amgen Inc.
$454
Alexion Pharmaceuticals, Inc.
$323
UCB, Inc.
$282
Janssen Biotech, Inc.
$265
Boehringer Ingelheim Pharmaceuticals, Inc.
$188
Lilly USA, LLC
$107
GlaxoSmithKline, LLC.
$90
Novartis Pharmaceuticals Corporation
$62
PFIZER INC.
$25
AstraZeneca Pharmaceuticals LP
$20
Sandoz Inc.
$18
Top 3 companies account for 60.7% of 2024 payments
All-time payments by company (2019-2024) ›
ABBVIE INC.
$873
Amgen Inc.
$562
AbbVie Inc.
$421
Janssen Biotech, Inc.
$357
Alexion Pharmaceuticals, Inc.
$337
UCB, Inc.
$315
Novartis Pharmaceuticals Corporation
$216
Boehringer Ingelheim Pharmaceuticals, Inc.
$188
GlaxoSmithKline, LLC.
$168
Lilly USA, LLC
$149
AstraZeneca Pharmaceuticals LP
$60
PFIZER INC.
$42
Sandoz Inc.
$42
Fresenius Kabi USA, LLC
$30
Aurinia Pharma U.S., Inc.
$23
Mylan Institutional Inc.
$18
Nestle HealthCare Nutrition Inc.
$15
Top 3 companies account for 48.6% of all-time payments
Associated products mentioned in payments ›
BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · ENTRESTO · EVENITY · Enbrel · HUMIRA · HYRIMOZ · Hulio · IDACIO · ILARIS · LUPKYNIS · OFEV · REMICADE · RINVOQ · SKYRIZI · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · XELJANZ · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Elgin?
Compare rheumatologists in the Elgin area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
59
Per 100K population
11.4
County median income
$100,678
Nearest hospital
ADVOCATE SHERMAN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Siddiqui is a mixed practice specialist, with above-average Medicare volume (top 21% in IL), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Siddiqui experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Siddiqui performed 24,080 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Siddiqui receive payments from pharmaceutical companies?
Yes. Dr. Siddiqui received a total of $3,817 from 17 companies across 166 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Siddiqui's costs compare to other rheumatologists in Elgin?
Dr. Siddiqui's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Siddiqui) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →